Koh Fujinaga
- Molecular Biology top 5%
- Virology top 0.2%
- Infectious Diseases top 2%
- Immunology top 5%
- Oncology top 10%
- Co-authors
- B. Matija PeterlinRan TaubeDavid H. PriceDan IrwinThomas P. CujecKoen BartholomeeusenDaniele C. CaryYanhui Xiang
- Topics
- HIV Research and Treatment (48 papers)RNA Research and Splicing (24 papers)HIV/AIDS drug development and treatment (21 papers)
- Journals
- Proceedings of the National Academy of SciencesNucleic Acids ResearchJournal of Biological Chemistry
- Partner nations
- United StatesJapanGermany
In The Last Decade
Koh Fujinaga
72 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 99
- Molecular Biology 2.2k
- Virology 1.6k
- Infectious Diseases 773
- Immunology 716
- Oncology 447
Countries citing papers authored by Koh Fujinaga
This map shows the geographic impact of Koh Fujinaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koh Fujinaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koh Fujinaga more than expected).
Fields of papers citing papers by Koh Fujinaga
This network shows the impact of papers produced by Koh Fujinaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koh Fujinaga. The network helps show where Koh Fujinaga may publish in the future.
Co-authorship network of co-authors of Koh Fujinaga
This figure shows the co-authorship network connecting the top 25 collaborators of Koh Fujinaga. A scholar is included among the top collaborators of Koh Fujinaga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koh Fujinaga. Koh Fujinaga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 70 | |
| 3 | 6 | |
| 4 | 5 | |
| 5 | 16 | |
| 6 | 17 | |
| 7 | 40 | |
| 8 | 61 | |
| 9 | 154 | |
| 10 | 2 | |
| 11 | 42 | |
| 12 | 12 | |
| 13 | 15 | |
| 14 | 27 | |
| 15 | 22 | |
| 16 | 117 | |
| 17 | 71 | |
| 18 | Inhibition of HIV-1 replication by targeting the Rev protein. | 5 |
| 19 | 10 | |
| 20 | E Growth dominance of a revertant virus generated during in vitro serial passage of nef frameshift mutant of HIV-1. | 1 |
About Koh Fujinaga
Koh Fujinaga is a scholar working on Virology, Infectious Diseases and Molecular Biology, having authored 72 papers that have together received 3.5k indexed citations. Recurring topics across this work include HIV Research and Treatment (48 papers), RNA Research and Splicing (24 papers) and HIV/AIDS drug development and treatment (21 papers). The work is most often cited by research in Virology (1.6k citations), Infectious Diseases (773 citations) and Immunology (716 citations). Koh Fujinaga has collaborated with scholars based in United States, Japan and Germany. Frequent co-authors include B. Matija Peterlin, Ran Taube, David H. Price, Dan Irwin, Thomas P. Cujec, Koen Bartholomeeusen, Daniele C. Cary, Yanhui Xiang, Ye-Hong Huang and Sheng‐Hao Chao. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.